Board Business:
Zhang Promoted to Associate Professor with Tenure, Dammeyer and Insley
Join Board
A faculty promotion and the appointment of two new board members were
approved at a recent meeting of The Scripps Research Institute (TSRI)
Board of Trustees.
Zhang Receives Tenure
Investigator Dong-Er Zhang is now associate professor with tenure in
the Department of Molecular and Experimental Medicine. Zhang (B.S., Peking
University; Ph.D., University of Houston) came to TSRI in 1999. Zhang's
major research interests center around the transcriptional regulation
in blood cell differentiation and the function of a ubiquitin-like modifier
ISG15 in signal transduction.
Other faculty members recently receiving promotions include:
• Francisco J. Asturias, promoted to associate professor in the
Department of Cell Biology;
• David Alexander Calderwood, promoted to assistant professor of
the Department of Cell Biology;
• Miguel A. del Pozo, promoted to assistant professor in the Department
of Immunology;
• Philippe Gallay, promoted to associate professor in the Department
of Immunology;
• Richard Klemke, promoted to associate professor in the Department
of Immunology;
• Erica Ollmann Saphire, promoted to assistant professor in the Department
of Immunology;
• Masahiro Aoki, promoted to assistant professor in the Department
of Molecular and Experimental Medicine, Division of Oncovirology;
• Andrew Gale, promoted to assistant professor in the Department
of Molecular and Experimental Medicine, Division of Experimental Hemostasis
and Thrombosis.
Dammeyer and Insley Join Board
The board welcomed new trustees Rod Dammeyer and Thomas Insley.
Dammeyer is president of CAC, LLC, a private company offering capital
investment and management advisory services.
His previous positions include: managing partner of Equity Group Corporate
Investments (1995-2000), CEO of Itel Corporation (1985-1995), senior vice
president and chief financial officer of Household International, Inc.
(1983-85), executive vice president and chief financial officer of Northwest
Industries (1979-83), and member, then partner, of Arthur Andersen & Co.
(1962-79).
A graduate of Kent State University, Dammeyer is a member of the boards
of directors of GATX Corporation, Stericycle, Inc., TeleTech Holdings,
Inc., and TheraSense, Inc., in addition to several private companies.
He is also a trustee of Van Kampen Funds (investment funds of Morgan Stanley),
and the University of Chicago Hospitals & Health System.
Insley is vice president and chief financial officer of SkinMedica,
Inc., a privately held specialty pharmaceutical company.
From 2002 to 2003, Insley was chief financial officer, corporate secretary,
and member of the Board of Directors of Molecular Imaging Corporation,
a publicly traded company that provides Positron Emission Tomography services
to hospitals and medical clinics. Prior to this position, Insley spent
29 years with PricewaterhouseCoopers, where he had major client responsibilities
in the wireless communications, software, and life sciences industries.
Insley, who has a B.A. in accounting from Franklin and Marshall College,
is currently on the board of directors of NexPrise, and is active in the
American Institute of Certified Public Accountants and California Society
of CPAs, BIOCOM San Diego, San Diego Regional Economic Development Corporation,
The Globe Theatres, and UC San Diego Foundation.
Board Thanks Safer
In addition, the board passed a resolution expressing its gratitude
to successful entrepreneur and world-renowned sculptor John Safer, who
is retiring from the board after seven years of service. The board extended
"its deepest appreciation and gratitude to John Safer for his wise stewardship,
outstanding leadership, and unstinting service to the institute, its mission,
and its achievements."
Go back to News & Views Index
|
Dong-Er Zhang is associate professor in the Department of Molecular
and Experimental Medicine, Division of Oncovirology. Photo
by Michael Balderas.
|
